Optimize IAS
  • Home
  • About Us
  • Free Initiatives
    • Daily Practice Sheets
    • Daily Prelims Notes
    • Prelims Power Play
    • Mains Factly
    • Sunday Essay Sadhna
    • Mains Master Notes
  • Courses
    • Prelims 2023
      • Laqshya 2023
      • Laqshya 2023 OPTIMA
    • Integrated Guidance 2023
      • ARJUNA Prime 2023
      • ARJUNA 2023
    • Mains Guidance 2023
      • DPS Prime (Current)
      • Mains Mentorship Program (Static)
    • CSE Interview Mentorship
    • ESSAY MASTER CLASS 2023
    • ETHICS MASTER CLASS 2023
  • Downloads
    • Daily Prelims Notes Compilation
    • Daily Practice Sheet Compilation
    • PPP Compilation
    • PSIR Notes
    • General Studies Notes
    • UPSC Mains Previous Year Papers
  • Portal Login
  • Home
  • About Us
  • Free Initiatives
    • Daily Practice Sheets
    • Daily Prelims Notes
    • Prelims Power Play
    • Mains Factly
    • Sunday Essay Sadhna
    • Mains Master Notes
  • Courses
    • Prelims 2023
      • Laqshya 2023
      • Laqshya 2023 OPTIMA
    • Integrated Guidance 2023
      • ARJUNA Prime 2023
      • ARJUNA 2023
    • Mains Guidance 2023
      • DPS Prime (Current)
      • Mains Mentorship Program (Static)
    • CSE Interview Mentorship
    • ESSAY MASTER CLASS 2023
    • ETHICS MASTER CLASS 2023
  • Downloads
    • Daily Prelims Notes Compilation
    • Daily Practice Sheet Compilation
    • PPP Compilation
    • PSIR Notes
    • General Studies Notes
    • UPSC Mains Previous Year Papers
  • Portal Login

Anti-cancer CAR-T therapy reengineers T cells to kill tumours — and researchers are expanding the limited types of cancer it can target

  • December 16, 2022
  • Posted by: OptimizeIAS Team
  • Category: DPN Topics
No Comments
Print Friendly, PDF & Email

 

 

Anti-cancer CAR-T therapy reengineers T cells to kill tumours — and researchers are expanding the limited types of cancer it can target

Subject: Science and Technology

Context-

  • Researchers have been developing a novel type of therapy that directly gives patients a new set of T cells engineered to attack tumours: chimeric antigen receptor T cells, or CAR-T cells for short.

What are T cells?

  • T cells are a type of white blood cell.
  • Also called T lymphocyte and thymocyte.
  • T cells are part of the immune system and develop from stem cells in the bone marrow. They help protect the body from infection and may help fight cancer.

What is CAR-T cell therapy and how does it work?

  • CAR-T cell therapy is a treatment to cure several types of cancer including lymphoma and multiple myeloma.
  • It starts with isolating a patient’s T cells from a sample of their blood.
  • These T cells are genetically engineered to produce a chimeric antigen receptor or CAR.
    • CARs are synthetic receptors specifically designed to redirect T cells from their usual targets to recognize and kill the tumour cells.
  • On the outside of a CAR is a binder that allows the T cell to stick to tumour cells.
  • Binding to a tumour cell activates the engineered T cell to kill and produce inflammatory cytokines proteins that support T cell growth and function and boost their cancer-killing abilities.
  • These CAR-T cells are then stimulated to divide into large numbers over seven to 10 days, and then given back to the patient via infusion.

For which type of cancers the therapy is effective?

  • It’s already being used to treat lymphoma and multiple myeloma.
  • However, it is not effective against solid tumours.
    • Unlike cancers that begin in the blood, these types of cancers grow into a solid mass (For e.g.KIdney or Pancreas) that produces a microenvironment of molecules, cells and structures that prevent T cells from entering into the tumour and triggering an immune response.
    • Here, even CAR-T cells engineered to specifically target a patient’s unique tumour are unable to access it, suppressing their ability to kill tumour cells.

Synthetic Notch Receptor (SynNotch):

  • Researchers have developed a new synthetic receptor that could complement the first CAR design.
  • This receptor, called synthetic Notch receptor, or synNotch, is based on the natural form of Notch in the body, which plays an important role in organ development across many species.
  • Similar to CARs, the outside of synNotch has a binder that allows T cells to stick to tumour cells.
  • Unlike CARs, the inside of synNotch has a protein that is released when a T cell binds to the tumour.
  • This protein, or transcription factor, allows researchers to better control the T cell by inducing it to produce a specific protein.

Use of synNotch in cancer treatment:

  • One of the most useful applications of synNotch thus far has been to use it to ensure that engineered T cells are only activated when bound to a tumour cell and not healthy cells.
  • If successful, the T cells will now require both CAR and synNotch receptors to recognize tumours, this increases the precision of T cell killing.
  • Then it could be used to improve CAR-T cell therapy against solid tumours by inducing them to produce more of the inflammatory cytokines, such as IL-2, that enable them to kill tumour cells.
  • So researchers have designed CAR-T cells to produce IL-2 using synNotch.
  • Now, when a CAR-T cell encounters a tumour, it produces IL-2 within the tumour instead of outside it, avoiding causing harm to surround healthy cells.
  • Because synNotch is able to bypass the barriers tumours put up, it is able to help T cells amp up and maintain the amount of IL-2 they can make, allowing the T cells to keep functioning even in a hostile microenvironment.
Anti-cancer CAR-T therapy reengineers T cells to kill tumours — and researchers are expanding the limited types of cancer it can target Science and tech
Print Friendly, PDF & Email
Loading

Recent Posts

  • Prelims Power Play 2 February 2023 February 3, 2023
  • Daily Practice Sheet 3 February 2023 February 3, 2023
  • Why is India lagging behind in science and technology? February 3, 2023
  • What is LIFE mission of India? How it can help check climate change? February 3, 2023
  • What is carrying capacity? Why it is important? February 3, 2023
  • What do you understand by inclusive growth? Discuss its need and various strategies to achieve it. February 3, 2023
  • What is a republic? How it is different from monarchical political system. February 3, 2023
  • Discuss the need for women reservation. February 3, 2023
  • Discuss the strategic significance of Ladakh February 3, 2023
  • Daily Prelims Notes 3 February 2023 February 3, 2023

About

If IAS is your destination, begin your journey with Optimize IAS.

Hi There, I am Santosh I have the unique distinction of clearing all 6 UPSC CSE Prelims with huge margins.

I mastered the art of clearing UPSC CSE Prelims and in the process devised an unbeatable strategy to ace Prelims which many students struggle to do.

Free Initiatives

  • Daily Practice Sheets
  • Daily Prelims Notes
  • Mains Factly
  • Prelims Power Play
  • Sunday Essay Sadhna

My Proven Strategy

  • Interview Strategy
  • Mains Strategy
  • Motivational
  • Prelims Strategy

Contact us

moc.saiezimitpo@tcatnoc

For More Details

Work with Us

Connect With Me

Santosh Pandey Quora Santosh Sir Telegram Santosh Sir Youtube Optimize IAS Instagram

Course Portal
Search